Learn More
The mechanisms of resistance to anti-human epidermal growth factor receptor 2 (HER 2) therapies are unclear but may include the tyrosine-protein kinase Met (c-Met), vascular endothelial growth factor(More)
7561 Background: In this retrospective analysis, we tested if the timing of interferon (iFN) as adjuvant or as treatment of the relapse, when correlated with CEACAM-1 intensity, affects survival. (More)
BACKGROUND The thymidine phosphorylase (TP) enzyme is expressed in higher levels in cancer tissue when compared with normal tissue. It is involved in the intratumoral activation of widely prescribed(More)